Engineers Gate Manager LP Adicet Bio, Inc. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.21 - $2.4 $931 - $1,848	-770 Reduced 2.99%	24,999 $30,000
Q1 2024 May 15, 2024	BUY	$1.76 - $3.45 $45,353 - $88,903	25,769 New	25,769 $60,000
Q2 2023 Aug 14, 2023	BUY	$2.13 - $7.13 $54,832 - $183,547	25,743 Added 118.8%	47,413 $115,000
Q1 2023 May 15, 2023	SELL	$5.52 - $9.23 $121,859 - $203,761	-22,076 Reduced 50.46%	21,670 $124,000
Q4 2022 Feb 14, 2023	BUY	$7.72 - $21.27 $337,719 - $930,477	43,746 New	43,746 $391,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $171,957 - $348,775	16,760 New	16,760 $245,000
Q1 2022 May 16, 2022	SELL	$11.53 - $19.97 $157,845 - $273,389	-13,690 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.37 - $17.49 $100,895 - $239,438	13,690 New	13,690 $239,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $35.6M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.